[1]陈　伟,侯湘岭.老年慢性心力衰竭患者血清人类母系表达基因3的水平与预后的相关性研究[J].现代检验医学杂志,2022,37(03):26-32.[doi:10.3969/j.issn.1671-7414.2022.03.006]
　CHEN Wei,HOU Xiang-ling.Study on the Correlation between Serum Human Maternally Expressed Gene 3 Levels and Prognosis in Elderly Patients with Chronic Heart Failure[J].Journal of Modern Laboratory Medicine,2022,37(03):26-32.[doi:10.3969/j.issn.1671-7414.2022.03.006]
点击复制

老年慢性心力衰竭患者血清人类母系表达基因3的水平与预后的相关性研究()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第37卷
期数:
2022年03期
页码:
26-32
栏目:
论　著
出版日期:
2022-05-15

文章信息/Info

Title:
Study on the Correlation between Serum Human Maternally Expressed Gene 3 Levels and Prognosis in Elderly Patients with Chronic Heart Failure
文章编号:
1671-7414（2022）03-026-07
作者:
陈　伟; 侯湘岭
（保定市第二医院心血管内科，河北保定 071000）
Author(s):
CHEN Wei;  HOU Xiang-ling
(Department of Cardiovascular Medicine，the Second Hospital of Baoding, Hebei Baoding 071000，China)
关键词:
老年患者; 慢性心力衰竭; 人类母系表达基因3
分类号:
R541.6；R446.11
DOI:
10.3969/j.issn.1671-7414.2022.03.006
文献标志码:
A
摘要:
目的　探讨老年慢性心力衰竭（ chronic heart failure，CHF）患者血清人类母系表达基因 3（maternally expressed gene 3，MEG3）表达与预后的相关性。方法　回顾性分析 2019年 1月～ 12月保定市第二医院收治的 118例 CHF患者的临床资料。比较 NYHA分级Ⅱ级和Ⅲ级患者的血清肌酸激酶同工酶（ creatine kinase isoenzyme-MB，CKMB）、心肌肌钙蛋白 I（cardiac troponin I，cTnI）、B型尿钠肽（ B-type natriuretic peptide，BNP）、MEG3表达、左室收缩末期内径（ left ventricular end-systolic dimension，LVESD）、左室舒张末期内径（ left ventricular end-diastolic dimension，LVEDD）、左室射血分数（ left ventricular ejection fractions，LVEF）。采用 Spearman相关性分析上述指标与心功能分级的相关性。根据患者随访 12个月期间是否出现心脏事件分为预后不良组和预后良好组，比较两组临床资料，采用多因素 Logistic回归分析确定预后影响因素，绘制血清 MEG3表达预测老年 CHF预后的 ROC曲线。结果　与心功能Ⅱ级相比较，心功能Ⅲ级患者血清 CK-MB（57.70±5.46 IU/L vs 68.19±6.53 IU/L），cTnI（1.95±0.47 ng/L vs 2.37±0.63 ng/L），BNP（336.43±67.38 pg/ml vs 581.21±98.73 pg/ml），MEG3表达（ 7.32±2.25 vs 11.65±3.09）及 LVESD（39.63±7.28 mm vs 44.18±8.4 mm），LVEDD（53.05±8.78 mm vs 58.73±9.02 mm）升高， LVEF（43.19%±5.66% vs 37.55%±5.94%）降低，差异具有统计学意义（ t= 2.690～ 12.932，均 P＜ 0.05）。经 Spearman相关分析，心功能分级与 CK-MB，cTnI，BNP，MEG3表达及 LVESD，LVEDD均呈显著正相关（ r = 0.339～ 0.472，均 P＜ 0.05），与 LVEF呈显著负相关（ r = -0.443，P＜ 0.05）。与预后良好组相比，预后不良组患者中年龄 71～ 80岁占比（ 32.93% vs 55.56%）和 NYHA分级Ⅲ级占比（ 65.85% vs 88.89%），血清 CK-MB（56.91±6.76 IU/L vs 84.84±9.79 IU/L），cTnI（1.87±0.44 ng/L vs 3.14±0.87 ng/L）， BNP（320.91±74.13 pg/ml vs 956.53±121.72 pg/ml）， MEG3表达（ 7.19±2.04 vs 17.96±4.81）和 LVESD（36.75±7.79 mm vs 57.06±10.05 mm），LVEDD（52.59±7.11 mm vs 67.67±9.46 mm）升高，LVEF（42.38%±5.93 % vs 31.56%±4.43 %）降低，差异均有统计学意义（ χ2=5.345，6.716，t= 7.876～ 27.650，均 P<0.05）。多因素 Logistic回归分析显示，年龄（ OR=3.615，95%CI：1.189～ 10.991），NYHA分级（ OR=3.911， 95%CI：1.324～ 11.553），血清 CK-MB（OR=3.554，95%CI：1.397～ 9.041），cTnI（OR=4.193，95%CI：1.583～ 11.106）， BNP（OR=2.842，95%CI：1.319～ 6.124），MEG3表达（ OR=5.003，95%CI：1.297～ 19.298），LVEF（OR=0.396， 95%CI：0.184～ 0.876）是预后影响因素（均 P＜ 0.05）。血清 MEG3表达预测 CHF预后的曲线下面积 0.874（95%CI： 0.778～ 0.948），当血清 MEG3表达 =12.52×2-△△ Ct时，敏感度与特异度最高，分别为 0.869，0.724。结论　年龄、 NYHA分级、血清 CK-MB，cTnI，BNP，MEG3表达及 LVEF是 CHF患者的预后影响因素，积极检测血清 MEG3表达有利于预测患者预后。
Abstract:
Objective　To investigate the relationship between the expression of serum human maternally expressed gene 3 (MEG3) and prognosis in elderly patients with chronic heart failure (CHF). Methods　The clinical data of 118 CHF patients admitted to the Second Hospital of Baoding from January 2019 to December 2019 were retrospectively analyzed. The serum creatine kinase isoenzyme (CK-MB), cardiac troponin I (cTnI), B-type natriuretic peptide (BNP), MEG3 expression, and left ventricular end-systolic diameter (LVESD), left ventricular end diastolic diameter (LVEDD), left ventricular ejection fraction (LVEF) were compared in NYHA grade II and III patients. Spearman correlation was used to analyze the correlation between the above indicators and the classification of cardiac function. Patients were divided into poor prognosis group and good prognosis group according to whether there were cardiac events during the 12-month follow-up period. The clinical data of the two groups were compared, multivariate logistic regression analysis was used to determine the prognostic factors, and the ROC curve of serum MEG3 expression to predict the prognosis of elderly CHF was drawn. Results　Compared with cardiac function grade II, serum CK-MB in patients with cardiac function grade III (57.70±5.46 IU/L vs 68.19±6.53 IU/L), cTnI (1.95±0.47 ng/L vs 2.37±0.63 ng/L), BNP (336.43±67.38 pg/ml vs 581.21±98.73 pg/ml), MEG3 expression (7.32±2.25 vs 11.65±3.09) and LVESD (39.63±7.28 mm vs 44.18±8.4 mm), LVEDD (53.05±8.78 mm vs 58.73±9.02 mm) were increased, the LVEF (43.19%±5.66% vs 37.55%±5.94%) was decreased, the difference were statistically significant (t = 2.690 ~ 12.932, all P<0.05). According to Spearman correlation analysis, cardiac function classification was significantly positively correlated with CK-MB, cTnI, BNP, MEG3 expression and LVESD, LVEDD (r = 0.339 ~ 0.472, all P<0.05), and significantly negatively correlated with LVEF (r =-0.443, P<0.05). Compared with the good prognosis group, the proportion of patients aged 71 to 80 years old in poor prognosis group (32.93% vs 55.56%) and the proportion of NYHA grade III (65.85% vs 88.89%), serum CK-MB (56.91±6.76 IU/L vs 84.84±9.79 IU/L), cTnI (1.87±0.44 ng/L vs 3.14±0.87 ng/L), BNP (320.91±74.13 pg/ml vs 956.53±121.72 pg/ml), MEG3 expression (7.19±2.04 vs 17.96±4.81), LVESD (36.75±7.79 mm vs 57.06±10.05 mm), LVEDD (52.59±7.11 mm vs 67.67±9.46 mm) were increased, the LVEF (42.38%±5.93% vs 31.56%±4.43%) was decreased, the difference were statistically significant (χ2=5.345, 6.716, t = 7.876 ~ 27.650, all P<0.05). Multivariate logistic regression analysis showed that age (OR=3.615, 95%CI: 1.189 ~ 10.991), NYHA classification (OR=3.911, 95%CI: 1.324 ~ 11.553), serum CK-MB (OR=3.554, 95%CI: 1.397 ~ 9.041), cTnI (OR=4.193, 95%CI: 1.583 ~ 11.106), BNP (OR=2.842, 95%CI: 1.319 ~ 6.124), MEG3 expression (OR=5.003, 95%CI: 1.297 ～ 19.298), LVEF (OR=0.396, 95%CI: 0.184 ～ 0.876) were prognostic factors ( all P<0.05). The area under the curve of serum MEG3 expression predicting the prognosis of CHF was 0.874 (95%CI: 0.778 ~ 0.948). When serum MEG3 expression=12.52×2- △△ Ct, the sensitivity and specificity were 0.869 and 0.724 respectively for the highest. Conclusion　 The age, NYHA grade, serum CK-MB, cTnI, serum BNP, MEG3 expression, LVEF are the prognostic factors of CHF patients. Active detecting the serum MEG3 expression level of patients has great predictive value for the prognosis of patients.

参考文献/References:

[1] 刘兆杰, 杨娟, 李文茜. 慢性心力衰竭相关的炎性因子的探讨[J]. 心血管病学进展, 2018, 39(3):388-391. LIU Zhaojie, YANG Juan, LI Wenqian. Investigation of inflammatory factors associated with chronic heart failure [J]. Advances in Cardiovascular Diseases, 2018,39(3):388-391.
[2] 周杨, 孟祥丽, 张继伟, 等. 长链非编码RNA 在心 血管疾病中的研究进展[J]. 基因组学与应用生物学, 2017, 36(5): 1876-1881. ZHOU Yang, MENG Xiangli, ZHANG Jiwei, et al. Research progress of long non-coding RNA in cardiovascular disease [J]. Genomics and Applied Biology,2017,36(5):1876-1881.
[3] 刘崇韬, 翁志远, 郑志虹. 急性心肌梗死患者血浆中 MEG3 和 UCA1 的表达水平及临床意义[J]. 心血管 康复医学杂志, 2019, 28(3):285-289. LIU Chongtao, WENG Zhiyuan, ZHENG Zhihong. Plasma expression levels of MEG3 and UCA1 in patients with acute myocardial infarction and their clinical significance [J]. Chinese Journal of Cardiovascular Rehabilitation Medicine, 2019, 28(3):285-289.
[4] 中华医学会心血管病学分会, 中华心血管病杂志编 辑委员会. 中国心力衰竭诊断和治疗指南2014[J]. 中华心血管病杂志,2014,42(2):98-122. Chinese Society of Cardiology, Editorial Board of Chinese Journal of Cardiology. Chinese guidelines for the diagnosis and trentment of heart failure 2014 [J]. Chinese Journal of Cardiology, 2014, 42(2):98-122.
[5] 刘晓灵, 高世定. 不同NYHA 分级慢性心力衰竭患 者心肌纤维化指标水平与心电图变化的临床意义 [J]. 武警医学, 2018, 29(11):1028-1031, 1035. LIU Xiaoling, GAO Shiding. Changes of myocardial fibrosis indexes and of ST-T and T peaks in patients with chronic heart failure with different NYHA classification and their clinical significance [J]. Medical Journal of the Chinese People’s Armed Police Force, 2018, 29(11):1028-1031,1035.
[6] 张旭, 付强, 秦涛, 等. 急性胰腺炎患者血清长链非 编码RNA-MEG3 表达及意义[J]. 中华实用诊断与 治疗杂志, 2018, 32(1):28-30. ZHANG Xu, FU Qiang, QIN Tao, et al. Expression and significance of serum long non-coding RNA-MEG3 in patients with acute pancreatitis [J]. Journal of Chinese Practical Diagnosis and Therapy, 2018, 32(1):28-30.
[7] 赵彦叶, 潘国忠, 张爱真. 脂联素与慢性心力衰竭能 量代谢的相关研究[J]. 中华心脏与心律电子杂志, 2017, 5(1): 54-56. ZHAO Yanye, PAN Guozhong, ZHANG Aizhen, et al. Study on the relationship between adiponectin and energy metabolism in chronic heart failure[J]. Chinese Journal of Medicinal Guide, 2017, 5(1):54-56.
[8] 杨晓梅, 方明明, 王艳, 等. 老年慢性心力衰竭患者 血清炎性因子水平变化及其与心衰标志物和心功能 指标的相关性分析[J]. 微循环学杂志, 2020, 30(4): 60-63. YANG Xiaomei, FANG Mingming, WANG Yan, et al. Changes of serum inflammatory factors in elderly patients with chronic heart failure and their correlation with heart failure markers and cardiac function indicators [J]. Chinese Journal of Microcirculation, 2020, 30(4):60-63.
[9] 蔡珠虹, 赵静, 刘天佳, 等. 慢性心力衰竭患者N 端 脑钠肽前体、脑钠肽与患者心脏超声参数及炎症因 子的关系[J]. 现代生物医学进展, 2019, 19(8): 1459- 1462. CAI Zhuhong, ZHAO Jing, LIU Tianjia, et al. Relationship between N terminal pro-brain natriuretic peptide, brain natriuretic peptide, cardiac ultrasound parameters and inflammatory factors in patients with chronic heart failure[J].Progress in Modern Biomedicine, 2019,19(8):1459-1462.
[10] 赵金宝, 单毅, 赵力, 等. CK-MB 和cTnI 在尿毒症 合并急性左心衰竭患者中的变化趋势[J]. 中国循证 心血管医学杂志, 2017, 9(5): 563-565. ZHAO Jinbao, SHAN Yi, ZHAO Li, et al. Variation trend of creatine kinase MB and cardiac troponin I in patients with uremia complicated by acute left ventricular failure[J]. Chinese Journal of Evidence- Bases Cardiovascular Medicine, 2017, 9(5):563-565.
[11] 陈怡粤, 余小平, 陈胜华. 心力衰竭超声指数评价射 血分数中间范围型心力衰竭的临床价值[J]. 中国老 年学杂志, 2018, 38(10): 2342-2344. CHEN Yiyue, YU Xiaoping, CHEN Shenghua, et al. The clinical value of heart failure ultrasound index in evaluating heart failure with mid-range ejection fraction[J]. Chinese Journal of Gerontology, 2018, 38(10):2342-2344.
[12] 尉若川, 李虹, 石衍煤, 等. 左室射血分数保留性心 力衰竭住院患者回顾性分析[J]. 中国老年学杂志, 2018, 38(10): 2328-2329. WEI Ruochuan, LI hong, SHI Yanmei, et al. Retrospective analysis of inpatients with heart failure with preserved left ventricular ejection fraction[J]. Chinese Journal of Gerontology, 2018, 38(10):2328-2329.
[13] LORENZEN J M, THUM T. Long noncoding RNAs in kidney and cardiovascular diseases[J]. Nature Reviews Nephrology, 2016, 12(6): 360-373.
[14] 张旭慧, 孔鹏, 韩梅. MicroRNA 和lncRNA: 衰老相 关心血管疾病的重要调控因子[J]. 中国生物化学与 分子生物学报, 2017, 33(7): 645-649. ZHANG Xuhui, KONG Peng, HAN Mei. MicroRNA and lncRNA: the important regulatory factors of aging related cardiovascular diseases [J]. Chinese Journal of Biochemistry and Molecular Biology, 2017, 33(7): 645-649.
[15] WANG Zhihua, ZHANG Xiaojing, JI Yanxiao, et al. The long noncoding RNA Chaer definesan epigenetic checkpoint in cardiac hypertrophy[J]. Nature Medicine, 2016, 22(10): 1131-1139.
[16] UCHIDA S. Besides imprinting: Meg3 regulates cardiac remodeling in cardiac hypertrophy[J]. Circulation Research, 2017, 121(5): 486-487.
[17] 赵洋, 刘洋, 杨一波, 等. 长链非编码RNA 与心 血管疾病的研究进展[J]. 中国实验诊断学, 2017, 21(8): 1463-1466. ZHAO Yang, LIU Yang, YANG Yibo, et al. Research progress of non-coding RNA and cardiovascular disease[J]. Chin J Lab Diag, 2017, 21(8):1463-1466.
[18] VIERECK J, KUMARSWAMY R, FOINQUINOS A, et al. Long non-coding RNA Chast promotes cardiac remodeling[J]. Science Translational Medicine, 2016, 8(326): 326ra22.
[19] 马骏, 黄岚. 长链非编码RNA 在心血管系统中的研 究进展[J]. 中国循环杂志, 2016, 31(12): 1248-1250. MA Jun, HUANG Lan. Research progress of long non-coding RNA in cardiovascular system[J]. Chinese Circulation Journal, 2016, 31(12):1248-1250.
[20] GU Meng, ZHENG Aibin, TU Wenjuan, et al. Circulating lncRNAs as novel, non-Invasive biomarkers for prenatal detection of fetal congenital heart defects[J]. Cellular Physiology and Biochemistry, 2016, 38(4): 1459-1471.
[21] PICCOLI M T, GUPTA S K, VIERECK J, et al. Inhibition of the cardiac Fibroblast-enriched lncRNA meg3 prevents cardiac fibrosis and diastolic dysfunction[J]. Circulation Research, 2017, 121(5): 575-583.
[22] 徐大伟, 马鹏举, 高国军, 等. 长链非编码RNA MEG3 靶向miR-21 对胶质瘤U251 细胞增殖、侵袭 和迁移的影响[J]. 肿瘤学杂志, 2019, 25(6): 524-530. XU Dawei, MA Pengju, GAO Guojun, et al. The effect of long non-coding RNA MEG3 on cell proliferation, migration and invasion of glioma cell line U251 via targeting miR-21 [J]. Journal of Chinese Oncology, 2019, 25(6):524-530.
[23] 夏芳, 汪隆海, 方超, 等. 血清5 种生物标志物水平 联合检测对心力衰竭的诊断价值[J]. 现代检验医学 杂志, 2019, 34(4): 22-27. XIA Fang, WANG Longhai, FANG Chao, et al. Combined detection of serum 5 biomarkers for the diagnostic value of heart failure [J]. Journal of Modern Laboratory Medicine, 2019, 34(4):22-27.
[24] 黄晖, 郭玉刚, 朱伟俊. 强离子隙对急性心肌梗死致 急性心力衰竭的预测作用研究[J]. 现代检验医学杂 志, 2020, 35(4): 143-146. HUANG Hui, GUO Yugang, ZHU Junwei. Effect of strong ion gap on prediction of acute heart failure induced by myocardial infarction [J]. Journal of Modern Laboratory Medicine, 2020, 35(4): 143-146.

相似文献/References:

[1]李德璇,王玉明,杨红玲,等.亲环素A与慢性心力衰竭相关性的研究[J].现代检验医学杂志,2015,30(01):31.[doi:10.3969/j.issn.1671-7414.2015.01.009]
　LI De-xuan,WANG Yu-ming,YANG Hong-ling,et al.Study on the Relationship between Cyclophilin A and Chronic HeartFailure[J].Journal of Modern Laboratory Medicine,2015,30(03):31.[doi:10.3969/j.issn.1671-7414.2015.01.009]
[2]崔 贞,刘 文.慢性心力衰竭患者呋塞米治疗对血清NT-proBNP水平的影响[J].现代检验医学杂志,2019,34(03):144.[doi:10.3969/j.issn.1671-7414.2019.03.037]
　CUI Zhen,LIU Wen.Effects of Furosemide in Patientswith Chronic Heart Failure on Serum NT-proBNP[J].Journal of Modern Laboratory Medicine,2019,34(03):144.[doi:10.3969/j.issn.1671-7414.2019.03.037]
[3]易福凌,陈伟芝,王　禺.慢性心力衰竭患者血清 Mb，cTnI，IL-8 和 hs-CRP 水平表达与心功能分级的相关性研究[J].现代检验医学杂志,2021,36(03):58.[doi:10.3969/j.issn.1671-7414.2021.03.013]
　YI Fu-ling,CHEN Wei-zhi,WANG Yu.Correlation between the Expression of Serum MB, cTnI, IL-8, hs-CRP andCardiac Function in Patients with Chronic Heart Failure[J].Journal of Modern Laboratory Medicine,2021,36(03):58.[doi:10.3969/j.issn.1671-7414.2021.03.013]
[4]王　麟,陈惠新,李小燕.慢性心力衰竭患者血清TRPC1,sFRP5和NT-proBNP水平与心功能及疾病严重程度的临床研究[J].现代检验医学杂志,2021,36(06):6.[doi:10.3969/j.issn.1671-7414.2021.06.002]
　WANG Lin,CHEN Hui-xin,LI Xiao-yan.Study on the Relationship between Serum TRPC1, sFRP5 and NT-proBNP Levels and Cardiac Function and Disease Severity in Predicting with Chronic Heart Failure[J].Journal of Modern Laboratory Medicine,2021,36(03):6.[doi:10.3969/j.issn.1671-7414.2021.06.002]
[5]张卫东,乔明刚.老年心衰并发心律失常患者血清Ang-2，CysC水平及hs-CRP/PAB比值对临床预后评估的价值研究[J].现代检验医学杂志,2021,36(06):128.[doi:10.3969/j.issn.1671-7414.2021.06.027]
　ZHANG Wei-dong,QIAO Ming-gang.Value of Serum Ang-2, Cys C and Hs-CRP/PAB Ratio in the Evaluation of Clinical Prognosis in Elderly Patients with Heart Failure Complicated by Arrhythmia[J].Journal of Modern Laboratory Medicine,2021,36(03):128.[doi:10.3969/j.issn.1671-7414.2021.06.027]
[6]王新庄,孟建涛.慢性心力衰竭患者血清 lncRNA MALAT1的表达水平及其临床意义[J].现代检验医学杂志,2022,37(01):141.[doi:10.3969/j.issn.1671-7414.2022.01.028]
　WANG Xin-zhuang,MENG Jian-tao.Expression of lncRNA MALAT1 in Peripheral Blood of Patients with Chronic Heart Failure and Its Clinical Significance[J].Journal of Modern Laboratory Medicine,2022,37(03):141.[doi:10.3969/j.issn.1671-7414.2022.01.028]
[7]李岗峰,李刘文,刘　璐.慢性心力衰竭患者血清内源性Apela，NT-proBNP及CysC水平与并发肾功能不全的相关性分析[J].现代检验医学杂志,2022,37(03):167.[doi:10.3969/j.issn.1671-7414.2022.03.035]
　LI Gang-feng,LI Liu-wen,LIU Lu.Correlation Analysis of Serum Endogenous Apela, NT-proBNP, Cys C Levels and Renal Insufficiency in Patients with Chronic Heart Failure[J].Journal of Modern Laboratory Medicine,2022,37(03):167.[doi:10.3969/j.issn.1671-7414.2022.03.035]
[8]杨 婷a,赵茜茜,褚 杰a,等.慢性心力衰竭患者血清MCP-3，NRG-1β 和CF6 水平表达与疾病严重程度的相关性研究[J].现代检验医学杂志,2022,37(05):139.[doi:10.3969/j.issn.1671-7414.2022.05.027]
　YANG Tinga,ZHAO Qian-qian,CHU Jiea,et al.Study on the Correlation between the Expression of Serum MCP-3, NRG-1β and CF6 Levels in Patients with Chronic Heart Failure and the Severity of the Disease[J].Journal of Modern Laboratory Medicine,2022,37(03):139.[doi:10.3969/j.issn.1671-7414.2022.05.027]
[9]徐锦华a,王慧娟,励 国a,等.老年慢性心力衰竭患者血清SCD-1 和sVEGFR-2 表达水平及其与预后的评估价值研究[J].现代检验医学杂志,2023,38(04):191.[doi:10.3969/j.issn.1671-7414.2023.04.035]
　XU Jinhuaa,WANG Huijuan,LI Guoa,et al.Study on the Expression Level of Serum SCD-1 and sVEGFR-2 in Elderly Patients with Chronic Heart Failure and Its Prognostic Value[J].Journal of Modern Laboratory Medicine,2023,38(03):191.[doi:10.3969/j.issn.1671-7414.2023.04.035]
[10]林 艳,但汉良,余 扬,等.慢性心力衰竭患者血清miR-122 和miR-558 水平表达与心功能及心率变异性的相关性研究[J].现代检验医学杂志,2024,39(03):37.[doi:10.3969/j.issn.1671-7414.2024.03.006]
　LIN Yan,DAN Hanliang,YU Yang,et al.Correlation between Serum miR-122 and miR-558 Levels and Cardiac Function and Heart Rate Variability in Patients with Chronic Heart Failure[J].Journal of Modern Laboratory Medicine,2024,39(03):37.[doi:10.3969/j.issn.1671-7414.2024.03.006]

备注/Memo

备注/Memo:
作者简介：陈伟（1975-），女，本科，副主任医师，研究方向：慢性心力衰竭治疗，E-mail：hryq48983@sina.cn。
更新日期/Last Update: 1900-01-01